Richard Kovacs to Hypolipidemic Agents
This is a "connection" page, showing publications Richard Kovacs has written about Hypolipidemic Agents.
Connection Strength
0.094
-
Association of Fenofibrate Therapy With Long-term Cardiovascular Risk in Statin-Treated Patients With Type 2 Diabetes. JAMA Cardiol. 2017 04 01; 2(4):370-380.
Score: 0.071
-
The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011 Jun 25; 377(9784):2181-92.
Score: 0.024